4.5 Article

Application of decellularized human reticular allograft dermal matrix promotes rapid re-epithelialization in a diabetic murine excisional wound model

Journal

CYTOTHERAPY
Volume 23, Issue 8, Pages 672-676

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.jcyt.2020.11.009

Keywords

allograft; delayed wound healing; dermis; HR-ADM; wound healing; wounds

Funding

  1. MTF Biologics

Ask authors/readers for more resources

This study investigated the effects of HR-ADM application on wound closure using a diabetic murine model. The results showed that HR-ADM promoted rapid wound closure and minimized granulation tissue formation. HR-ADM also facilitated cellular infiltration, neovascularization, and collagen remodeling in the wounds.
Background aims: The treatment and care of human wounds represent an enormous burden on the medical system and patients alike. Chronic or delayed healing wounds are characterized by the inability to form proper granulation tissue, followed by deficiencies in keratinocyte migration and wound re-epithelialization, leading to increased likelihood of infection and poor wound outcomes. Human reticular acellular dermal matrix (HR-ADM) is one type of tissue graft developed to enhance closure of delayed healing wounds that has demonstrated clinical utility through accelerating closure of lower extremity diabetic ulcers, but the mechanisms underlying this clinical success are not well understood. Methods: The authors utilized a diabetic murine splinted excisional wound model to investigate the effects of HR-ADM application on wound closure. Results: The authors demonstrate that application of HR-ADM served as a dermal scaffold and promoted rapid re-epithelialization and keratinocyte proliferation, resulting in accelerated wound closure while minimizing granulation tissue formation. HR-ADM-applied wounds also demonstrated evidence of cellular infiltration, neovascularization and collagen remodeling by the host organism. Conclusions: These data suggest that HR-ADM supports epidermal closure in delayed healing wounds and remodeling of the matrix into host tissue, lending further support to the clinical success of HR-ADM described in clinical reports. (c) 2020 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available